Clinical Nurse Specialist in Dover, DE Accepting Medicare

9 Clinical Nurse Specialist nurses found. Showing 1 - 9

Felicia Cruz, APRN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-310-8148

Mrs. Debra W. Petro, APRN Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 121 W Loockerman St, Dover, DE 19904 Phone: 302-674-1397

Karin Cooney-newton, MSN, RN, APRN, CCRN Clinical Nurse Specialist - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-310-8522

Ludmila Santiago-rotchford, ACNS-BC Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6166

Mrs. Kimberly Kay Holmes, APRN, ACNS-BC Clinical Nurse Specialist - Neuroscience Medicare: Not Enrolled in Medicare Practice Location: 200 Banning St Ste 150, Dover, DE 19904 Phone: 302-744-6592    Fax: 302-735-3240

Sheila Lee Dirocco, APRN, AGCNS-BC Clinical Nurse Specialist - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6223

Robin Lynn Maracle, AGCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 530 S State St Ste 107, Dover, DE 19901 Phone: 302-608-5299    Fax: 302-608-3885

Gwynn Stup, A.P.R,N. Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 1326 S Governors Ave, Ste C, Dover, DE 19904 Phone: 302-222-8304    Fax: 302-736-1280

Genna Marie Thompson, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 540 S Governors Ave Ste 100, Dover, DE 19904 Phone: 302-744-6592    Fax: 302-735-3240

News Archive

Promising way to prevent disparities in colorectal cancer screening

People living in poverty are less likely to be screened regularly for colorectal cancer-and more likely to develop the disease and die from it. How to end these disparities-and raise screening rates, lower disease rates, and prevent deaths? A promising way is to mail fecal immunochemical tests (a newer kind of stool test) to populations, Beverly B. Green, MD, MPH, and Gloria D. Coronado, PhD, wrote in the June 17 JAMA Internal Medicine.

Pfizer discloses $35 million in payments to doctors, hospitals for research and promotion

Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).

Demonstrating cost and clinical benefits critical to expansion of European seed brachytherapy markets

The nascent European seed brachytherapy market has been grappling with issues of high procedural and investment costs and a lack of local clinical evidence. However, growing evidence of the overall clinical and cost benefits of seed brachytherapy coupled with rising patient awareness is set to boost market expansion.

Diabetes-related proteins seen in high-res for the first time

A team of researchers have reported, in an exciting study published in the journal Nature Communications, that they were able to examine an important receptor at high definition for the first time. This detailed visualization has helped them greatly to understand its mechanism of functioning. This could help develop better ways to treat Type 2 diabetes mellitus as well as other conditions.

Read more Medical News

› Verified 1 days ago